TyraTech, Inc.

("TyraTech" or the "Company")

Vamousse® head lice products now listed by top three distributors 

in the USA

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that its Vamousse head lice products are now listed by AmerisourceBergen, the second biggest distributor of pharmaceutical products in the USA, further paving the way for distribution to the large network of independent pharmacies in the USA.

This agreement follows the recently announced listings for Vamousse obtained with McKesson and Cardinal Health, the number one and number three distributors of pharmaceutical products in the USA respectively.

These listings represent an important milestone for Tyratech providing the essential first step in accessing the approximate 20,000 independent pharmacies in the USA. With combined estimated sales of more than $350 billion in 2014, these three distributors have specific programs designed to reach independent pharmacies and chains of local and regional pharmacies. The listings will now allow TyraTech to access these specific programs and progressively deploy its Vamousse products during 2015 and beyond.

Bruno Jactel, Chief Executive Officer, said: "This new listing with AmerisourceBergen marks another important step in the commercialisation of our core intellectual property and in the expansion of our distribution network for our Vamousse products. Following the recent listing of Vamousse Protection Shampoo at Walmart and the addition of Lloyds and Day Lewis in the UK, we are delighted to have added the three biggest distributors to independent pharmacies in the USA, giving us an important route into the 20,000 independent pharmacies in the USA. The team at TyraTech is very excited by the growth opportunities presented by the continually expanding distribution network for Vamousse products."

Further information on Vamousse™ is available on the Company's website at http://www.vamousselice.com/